Adenosine - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:55:24Z

Switch SMW query from broadtable to table format for better layout with TOC

← Older revision		Revision as of 21:55, 20 March 2026
Line 77:		Line 77:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T17:24:11Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

← Older revision		Revision as of 17:24, 20 March 2026
Line 79:		Line 79:
	\|format=broadtable		\|format=broadtable
	\|headers=plain		\|headers=plain
	\|~~link~~=~~subject~~		\|mainlabel=-
	\|sort=Has Indication		\|sort=Has Indication
	\|limit=50		\|limit=50

Danbot: Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

2026-03-20T16:42:20Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

@@ Line 66: / Line 66: @@
 *Negative inotropic, dromotropic, chronotropic effects
 *Transient AV nodal block
 ==See Also==

Kxl328 at 12:29, 19 June 2023

2023-06-19T12:29:15Z

← Older revision		Revision as of 12:29, 19 June 2023
Line 8:		Line 8:
	==Indications==		==Indications==
	*Conversion of reentrant PSVT to NSR		*Conversion of reentrant PSVT to NSR
	~~='''MAIN INDICATION is ASYSTOLE''' (per Dr. Austin Brown, MD from Memphis UT residency)=~~

	==Adult Dosing==		==Adult Dosing==

Kxl328: /* MAIN INDICATION is ASYSTOLE */

2023-06-19T12:27:39Z

MAIN INDICATION is ASYSTOLE

← Older revision		Revision as of 12:27, 19 June 2023
Line 8:		Line 8:
	==Indications==		==Indications==
	*Conversion of reentrant PSVT to NSR		*Conversion of reentrant PSVT to NSR
	='''MAIN INDICATION is ASYSTOLE'''=		='''MAIN INDICATION is ASYSTOLE''' (per Dr. Austin Brown, MD from Memphis UT residency)=

	==Adult Dosing==		==Adult Dosing==

Kxl328: /* Indications */

2023-06-19T12:26:42Z

Indications

← Older revision		Revision as of 12:26, 19 June 2023
Line 8:		Line 8:
	==Indications==		==Indications==
	*Conversion of reentrant PSVT to NSR		*Conversion of reentrant PSVT to NSR
	*='''ASYSTOLE'''=		='''MAIN INDICATION is ASYSTOLE'''=

	==Adult Dosing==		==Adult Dosing==

Kxl328: /* Indications */

2023-06-19T12:26:00Z

Indications

← Older revision		Revision as of 12:26, 19 June 2023
Line 8:		Line 8:
	==Indications==		==Indications==
	*Conversion of reentrant PSVT to NSR		*Conversion of reentrant PSVT to NSR
			*='''ASYSTOLE'''=

	==Adult Dosing==		==Adult Dosing==

Elcatracho: /* Stable, narrow complex tachycardia */

2021-02-11T22:34:31Z

Stable, narrow complex tachycardia

← Older revision		Revision as of 22:34, 11 February 2021
Line 15:		Line 15:
	**If still ineffective can try another 12mg		**If still ineffective can try another 12mg
	*Caveat		*Caveat
	**For patients taking methylxanthines (ie caffeine, theophylline):		**For patients taking methylxanthines (ie [[caffeine]], [[theophylline]]):
	***Blocks adenosine binding at receptor sites (competitive antagonist) and can lead to bronchospasm		***Blocks adenosine binding at receptor sites (competitive antagonist) and can lead to bronchospasm; requires larger dose of adenosine
	**Consider using lower dose (1st 3mg, 2nd/3rd 6mg) in patient taking [[carbamazepine]] (Tegretol), [[diazepam]] (Valium) or [[dipyridamole]] (Persantine) '''OR''' with a heart transplant.		**Consider using lower dose (1st 3mg, 2nd/3rd 6mg) in patient taking [[carbamazepine]] (Tegretol), [[diazepam]] (Valium) or [[dipyridamole]] (Persantine) '''OR''' with a heart transplant.
	*Traditionally given via stopcock with immediate flush secondary to very short half life. Newer study showing that you may be able to mix with normal saline and give as single push, however further evidence is still needed<ref>Single syringe administration of diluted adenosine McDowell M, Mokszycki R, Greenberg A, et al. [published online October 30, 2019] Acad Emerg Med. doi:10.1111/acem.13879</ref>.		*Traditionally given via stopcock with immediate flush secondary to very short half life. Newer study showing that you may be able to mix with normal saline and give as single push, however further evidence is still needed<ref>Single syringe administration of diluted adenosine McDowell M, Mokszycki R, Greenberg A, et al. [published online October 30, 2019] Acad Emerg Med. doi:10.1111/acem.13879</ref>.

Gpowellhb: /* Stable, narrow complex tachycardia */

2020-02-13T01:22:23Z

Stable, narrow complex tachycardia

← Older revision		Revision as of 01:22, 13 February 2020
Line 18:		Line 18:
	***Blocks adenosine binding at receptor sites (competitive antagonist) and can lead to bronchospasm		***Blocks adenosine binding at receptor sites (competitive antagonist) and can lead to bronchospasm
	**Consider using lower dose (1st 3mg, 2nd/3rd 6mg) in patient taking [[carbamazepine]] (Tegretol), [[diazepam]] (Valium) or [[dipyridamole]] (Persantine) '''OR''' with a heart transplant.		**Consider using lower dose (1st 3mg, 2nd/3rd 6mg) in patient taking [[carbamazepine]] (Tegretol), [[diazepam]] (Valium) or [[dipyridamole]] (Persantine) '''OR''' with a heart transplant.
			*Traditionally given via stopcock with immediate flush secondary to very short half life. Newer study showing that you may be able to mix with normal saline and give as single push, however further evidence is still needed<ref>Single syringe administration of diluted adenosine McDowell M, Mokszycki R, Greenberg A, et al. [published online October 30, 2019] Acad Emerg Med. doi:10.1111/acem.13879</ref>.

	==Pediatric Dosing==		==Pediatric Dosing==

ClaireLewis at 16:38, 19 September 2019

2019-09-19T16:38:45Z

← Older revision		Revision as of 16:38, 19 September 2019
Line 71:		Line 71:
	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:Cardiology]]